Dual Effects of Resveratrol on the Expression and Secretion of Angiogenic Factors.
Angiogenesis Inhibitors
Interleukin-8
Resveratrol
VEGF
VEGFR2
co-culture
Journal
International journal of molecular and cellular medicine
ISSN: 2251-9637
Titre abrégé: Int J Mol Cell Med
Pays: Iran
ID NLM: 101598104
Informations de publication
Date de publication:
2022
2022
Historique:
received:
29
12
2021
revised:
01
04
2022
accepted:
31
07
2022
entrez:
18
11
2022
pubmed:
19
11
2022
medline:
19
11
2022
Statut:
ppublish
Résumé
Angiogenesis is an essential process in the growth, development, and transition of tumors from dormancy to proliferating state. Resveratrol (RSV), as a natural polyphenolic compound, is claimed to be effective in regulating angiogenesis. This study aimed to evaluate the impact of RSV onthe angiogenesis process in HUVECs (human umbilical vein endothelial cells) alone and co-cultured with Jurkat cells. The effects of RSV on HUVECs and Jurkat cell viability and apoptosis were measured by MTT and Annexin-V/PI methods. HUVECs were co-cultured with pre-treated Jurkat cells and incubated for 24 h, 48 h and 72 h. The angiogenesis process in HUVECs and Jurkat cells alone and in co-culture models was investigated by analyzing the expression of VEGF, VEGFR-2, and Interleukin-8 (IL-8) employing qPCR and ELISA. RSV at low concentration (40 µM) had no significant effects on apoptosis rate of HUVECs, but higher concentrations (80-160 µM) increased apoptosis in co-culture method and HUVECs alone. RSV significantly reduced VEGFR2 and IL-8 gene expression also, IL-8 protein concentration in HUVECs, but the effects of this drug in the HUVECs-Jurkats co-culture were different. Expression of VEGF in Jurkat cells increased following treatment with RSV. RSV had direct anti-angiogenic effects on HUVECs. Unexpectedly its indirect effects were not significant on HUVECs-Jurkats co-culture. Results of our study showed, RSV may be effective in anti-angiogenesis therapy, but in some situations, it may induce angiogenesis. So, appropriate concentrations should achieve to minimize the unpredicted effects of RSV.
Identifiants
pubmed: 36397806
doi: 10.22088/IJMCM.BUMS.11.1.16
pmc: PMC9653554
doi:
Types de publication
Journal Article
Langues
eng
Pagination
16-30Déclaration de conflit d'intérêts
The authors declare that they have no conflict of interest.
Références
Ann N Y Acad Sci. 2016 Dec;1386(1):3-15
pubmed: 27880855
Bone Marrow Transplant. 2000 Mar;25(6):639-45
pubmed: 10734298
Cytokine. 2015 Dec;76(2):549-552
pubmed: 26174951
Molecules. 2020 Aug 19;25(17):
pubmed: 32824997
Hematology. 2015 Oct;20(9):504-10
pubmed: 25885121
Leukemia. 2009 Jan;23(1):162-9
pubmed: 18800145
Hematology Am Soc Hematol Educ Program. 2011;2011:1-8
pubmed: 22160005
Methods. 2001 Dec;25(4):402-8
pubmed: 11846609
Exp Cell Res. 2020 May 1;390(1):111934
pubmed: 32126236
J Thromb Haemost. 2005 Aug;3(8):1835-42
pubmed: 16102050
Toxins (Basel). 2019 Dec 13;11(12):
pubmed: 31847250
Respir Res. 2006 Mar 02;7:37
pubmed: 16512910
J Immunol. 2010 Jan 15;184(2):545-9
pubmed: 20008289
Pharmacol Res. 2018 Aug;134:238-245
pubmed: 30018026
Dis Markers. 2019 Nov 20;2019:8023460
pubmed: 31827643
Stem Cells Int. 2015;2015:498328
pubmed: 26106428
Cell Transplant. 2020 Jan-Dec;29:963689720929987
pubmed: 32463297
Rom J Morphol Embryol. 2018;59(2):455-467
pubmed: 30173249
Cell Cycle. 2007 Oct 15;6(20):2495-510
pubmed: 17726376
J Immunol. 2003 Mar 15;170(6):3369-76
pubmed: 12626597
J Agric Food Chem. 2019 Jan 30;67(4):1127-1137
pubmed: 30525561
Leuk Res. 2018 Jan;64:52-60
pubmed: 29190514
Haematologica. 2008 Apr;93(4):524-32
pubmed: 18322253
Blood Coagul Fibrinolysis. 2016 Sep;27(6):711-6
pubmed: 27472040
Angiogenesis. 2012 Sep;15(3):361-76
pubmed: 22451299
Genes Cancer. 2011 Dec;2(12):1097-105
pubmed: 22866201
Inflammation. 2019 Oct;42(5):1622-1629
pubmed: 31165327
Front Neurosci. 2018 Oct 04;12:690
pubmed: 30337851
Gene Ther. 2008 May;15(9):635-51
pubmed: 18273054
Expert Rev Clin Immunol. 2014 May;10(5):593-619
pubmed: 24678812
Cancers (Basel). 2020 Apr 15;12(4):
pubmed: 32326402
J Hematother Stem Cell Res. 2002 Feb;11(1):33-47
pubmed: 11847002
J R Soc Interface. 2014 Jul 6;11(96):
pubmed: 24829281
Int J Mol Sci. 2019 Apr 30;20(9):
pubmed: 31052341
J Nutr Biochem. 2016 Oct;36:21-30
pubmed: 27560195
Cancer Sci. 2019 Dec;110(12):3773-3787
pubmed: 31578782
J Biochem Mol Biol. 2006 Sep 30;39(5):469-78
pubmed: 17002866
Oncogene. 2013 May 30;32(22):2747-55
pubmed: 22797057
Crit Rev Oncol Hematol. 2007 May;62(2):105-18
pubmed: 17188504
Epigenetics. 2013 Jul;8(7):720-9
pubmed: 23803577